课题基金 / 基金详情

Development of new treatments against malignant bone and soft tissue tumors by using bisphosphonate and ionizing radiation

Development of new treatments against malignant bone and soft tissue tumors by using bisphosphonate and ionizing radiation
使用双膦酸盐和电离辐射开发针对恶性骨和软组织肿瘤的新疗法
批准号:
23592196
负责人:
MURATA Hiroaki
金额:
$3.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

MURATA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
用第三代双膦酸盐(bp)和/或电离辐射(IR)一起或依次治疗纤维肉瘤细胞,并评估抗肿瘤效果。bp显著增强了IR诱导的细胞凋亡,尤其是bp后IR处理的细胞。因此,我们评估了bp和IR顺序治疗的详细机制。低浓度bp对细胞周期中对辐射最敏感的G2期和M期细胞无明显影响。然而,在3gy辐照后短时间内,与放射适应抗性相关的Akt、ERK1/2和NF- B蛋白的表达水平升高,低浓度bp阻断了小gtpase的戊酰化,从而抑制了这种表达。这种顺序处理也增加了活性氧(ROS)的产生。
英文摘要
Fibrosarcoma cells were treated with third-generation bisphosphonate (BPs) and/or ionizing radiation (IR), together or sequentially, and the antitumor effects were assessed. BPs significantly enhanced IR-induced apoptosis, especially when cells were treated with BPs followed by IR. We therefore assessed the detailed mechanism of sequential treatment with BPs and IR. Cells in G2 and M phases, the most radiosensitive phases of the cell cycle, were not increased by low concentrations of BPs. However, the levels of expression of Akt, ERK1/2, and NF- B proteins, all of which are related to radioadaptive resistance, were increased within a short time after irradiation with 3 Gy, and this expression was inhibited by a low concentration of BPs, which blocked the prenylation of small GTPases. This sequential treatment also increased the generation of reactive oxygen species (ROS).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
線維肉腫細胞株に対するゾレドロン酸と放射線の併用による細胞内シグナル伝達経路への影響の検討
唑来膦酸与放射线联用对纤维肉瘤细胞系细胞内信号转导途径影响的研究
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [中田 浩史, 中村 篤志, 亀井 節也, 藤渕 剛次, 木谷 彰岐, 三浦 裕正, 宮崎 龍彦, 坂山 憲史, 小藤和孝,堀井基行,村田博昭,松井隆明,堀江直行,澤井泰志,久保俊一]
通讯作者: 小藤和孝,堀井基行,村田博昭,松井隆明,堀江直行,澤井泰志,久保俊一
DOI: 10.3892/ijo.2012.1735
发表时间: 2013-02-01
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY
影响因子: 5.2
作者: [Koto, Kazutaka, Murata, Hiroaki, Fushiki, Shinji]
通讯作者: Fushiki, Shinji
Combined effects of the Third-Generation Bisphosphonate and Radiation on Fibrosarcoma Cells
第三代双膦酸盐和放射线对纤维肉瘤细胞的联合作用
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Koto K, Murata H, Sakabe T, Matsui TA, Horie N, Sawai Y, Ashihara E, Kimura S, Maekawa T, Fushiki S, Kubo T]
通讯作者: Kubo T
線維肉腫細胞株に対する第3世代ビスフォスフォネートと放射線の併用による抗腫瘍効果の検討
第三代双膦酸盐联合放射治疗纤维肉瘤细胞系的抗肿瘤作用研究
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [松原孝夫, 楠崎克之, 中村知樹, 浅沼邦洋, 松峯昭彦, 須藤啓広., 小藤和孝,村田博昭,坂部智哉,松井隆明,堀江直行,澤井泰志,久保俊一]
通讯作者: 小藤和孝,村田博昭,坂部智哉,松井隆明,堀江直行,澤井泰志,久保俊一
共 7 条
    Development of novel analgesic strategy based on the intracellular localization analysis of opioid receptors using real time visualization assay
    • 批准号:
      18K08858
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2018
    • 负责人:
      MURATA Hiroaki
    • 依托单位:
    Development of non-operative treatment for local control and new bone formation against metastatic bone tumors
    • 批准号:
      26462274
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      MURATA Hiroaki
    • 依托单位:
    Optimization of opioid therapy based on the diversity of dimerized opioid receptors
    • 批准号:
      25462442
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      MURATA Hiroaki
    • 依托单位:
    Analysis of analgesic action of remifentanil through dimerized mu-delta opioid receptors
    • 批准号:
      22791441
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.5万
    • 财政年份:
      2010
    • 负责人:
      MURATA Hiroaki
    • 依托单位:
    海外基金